• thanks to the increased surface in relation to volume, the drug can
be released more efficiently

• a controlled release process, as in depot/delayed drug formulations
or in formulations which consist of initial and maintenance doses are
usually based on release through a retarding film coating. If this film is
not completely intact, drug release is no longer controlled.
Simultaneous perforation of the film in a large number of mini tablets is
unlikely. Thus, the release process can be controlled with greater certainty.

• by combining differently dosed mini tablets, it is possible to achieve
several different releases with one formulation.

• due to the significantly smaller dimensions of the mini tablets in
comparison to a normally sized tablet, the mini tablets pass through
the stomach at a more even rate. As a result, the absorption, and
therefore also the concentration of the drug in the blood can be more
easily reproduced than in the case of a normally sized tablet.